Naprod Life Sciences is a finished-dose manufacturer based in India. It appears in 206 regulatory filings across 16 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), INVIMA (CO) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil) and EMA. Customs aggregates show $17.5M of exports covering 599 molecules to 33 destinations in 2025.
| Site | FDA FEI |
|---|---|
| TARAPUR, India | Not on file |
| Mumbai, India | Not on file |
| Boisar, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 66 | None |
| INVIMA (CO) | 26 | None |
| ARCSA (EC) | 20 | None |
| MINSA (CR) | 19 | None |
| DAV (Vietnam) | 19 | None |
| TMDA (TZ) | 17 | None |
| ANVISA (Brazil) | None | 3 |
| EMA | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.8M | 24 |
| 2025 | Not reported | $17.5M | 33 |
| 2024 | Not reported | $16.0M | 39 |
| 2023 | Not reported | $14.2M | 38 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Naprod Life Sciences comes back tiered against every other supplier able to file there.
Start for free